Organized in coordination between the University of Geneva Faculty of Medicine  and the Geneva University Hospitals, Switzerland.

 

Download PDF Program 

Program:

 

Wednesday December 7, 2022

11.30 – 13.00 : Registration


13.00 – 13.20 : Introduction

Isabella EckerleGeneva Centre for Emerging Viral Diseases, Faculty of Medicine, University of Geneva and Geneva University Hospitals, Switzerland

Cem Gabay,  Faculty of Medicine, University of Geneva, Switzerland


Session I: Surveillance, models & biobanks – novel tools to fight virus emergence


Chairs: Jenna Kelly, University of Bern, Keith Harshman, Health 2030 Genome Center


13.25 – 13.45 :  

Modeling emerging infectious diseases: The past, the present, and the future

Christian Althaus, University of Bern, Switzerland

13.50 – 14.10

Wastewater-based Infectious Disease Surveillance

Tanja Stadler, ETH Zürich, Switzerland

14.15 – 14.35

WHO BioHub: the pilot phase

Nicole Liechti, Spiez Laboratory, Switzerland

14.40 - 15.00

Influenza surveillance 

David Wentworth, Centre for Disease Control and Prevention, USA (online)


 15.00 – 15.15: Discussion


 15.15 – 15.45 : Coffee Break


 Session II: Poxviruses in the spotlight - Monkeypox and other orthopoxviruses


Chairs: Laurent Kaiser, Geneva Centre for Emerging Viral Diseases, Faculty of Medicine, University of Geneva and Geneva University Hospitals, Switzerland, Meriem Bekliz, Geneva Centre for Emerging Viral Diseases, Faculty of Medicine, University of Geneva, Switzerland


 15.45 – 16.05

The long and winding road to smallpox eradication

David Heymann, London School of Tropical Medicine & Hygiene, UK (online)

16.10 – 16.30

Waking up to monkeypox

Piero Olliaro, University of Oxford, UK

16.35 – 16.55

Uncovering the evolutionary history of variola virus using ancient DNA

Barbara Mühlemann, Charite University Hospital Berlin, Germany

17.00 – 17.20

A One Health approach of monkeypox in the Central African Republic

Emmanuel Nakoune, Institute Pasteur, Central African Republic


 17.20 – 17.35 : Discussion


 Evening lectures (Keynote)


 17.40 – 18.00

Welcome note
Laurent Kaiser, Geneva Centre for Emerging Viral Diseases, Faculty of Medicine, University of Geneva and Geneva University Hospitals, Switzerland Geneva University Hospitals, Switzerland

Alain Kolly, Geneva University Hospitals, Switzerland


 Chairs: Volker Thiel, University of Bern; Manuel Schibler, University Hospitals of Geneva


 18.00 - 18.30

The origin and genetic history of the plague: What we learn from ancient pandemics
Johannes Krause, Max Planck Institute for the Science of Human History, Jena and Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany (online)

18.30 -19.00
Covid-19 and beyond: Understanding emerging viral diseases and their public health impact globally
Maria van Kerkhove, World Health Organization, Geneva, Switzerland


Social program


19.00 : Apero Venue: Foyer Campus Biotech


 

Thursday December 8, 2022

Session I: Communication, misinformation & the infodemic


Chairs: Isabella Eckerle, Geneva Centre for Emerging Viral Diseases, Faculty of Medicine, University of Geneva and Geneva University Hospitals, Switzerland; Emma Hodcroft, University of Bern & Geneva

08.30 –08.50
The fight against infodemics
Sylvie Briand, World Health Organization, Geneva

08.55 - 09.15
Vaccine hesitancy
Heidi Larson, London School of Tropical Medicine & Hygiene, UK (online)

09.20 – 09.40
Three Ps in a Pandemic: On Trust and Truth
Kai Kupferschmidt, Science Journalist, Berlin


 09.40 – 09.55: Discussion


10.00 – 10.30 : Coffee break


Session II: Panel Discussion


10.30 – 12.00
Science, policy & pandemics –Better prepared for the next crisis?
Panel members:
Matthias Egger, SNSF
Volker Thiel, Vetsuisse Bern
Tanja Stadler, ETH Zürich 
Celine Gardiol, Federal Office of Public Health 
Alexandra Calmy, Faculty of Medicine, University of Geneva and Geneva University Hospitals


12.00 – 13.00 : Lunch, Venue: Foyer, Campus Biotech


Session III: SARS-CoV-2 immunity: From cells and antibodies to populations


Chairs: Didier Trono, EPFL, Olha Puhach, Geneva Centre for Emerging Viral Diseases, Faculty of Medicine, University of Geneva and Geneva University Hospitals, Switzerland


13.00 – 13.20
Seroprevalence of anti-SARS-CoV-2 antibodies in Geneva: a tale of two years
Maria Eugenia Zaballa, Geneva University Hospitals, Switzerland

13.25 - 13.45
Protective effectiveness of prior SARS-CoV-2 infection and hybrid immunity against Omicron infection and severe disease
Lorenzo Subissi, World Health Organization, Switzerland

13.50 - 14.10
Locking the Entry Door of SARS-CoV-2, are Mucosal Antibodies the Key?
Benjamin Meyer, University of Geneva, Switzerland

14.15 – 14.35
Why are children less affected than adults by SARS-CoV-2 infection? An immunological perspective
Arnaud Didierlaurent, University of Geneva, Switzerland


 14.35 – 14.50 : Discussion


14.50 – 15.20 : Coffee break


Session IV: Monoclonal antibodies & antiviral drugs against emerging viruses


Chairs: Caroline Tapparel, University of Geneva; Manel Essaidi-Laziosi, University of Geneva


15.20 – 15.40
Novel treatments against SARS-CoV-2
Alexandra Calmy, Geneva University Hospitals, Switzerland

15.45 - 16.05
Broad neutralization: linchpin for HIV vaccine development
Alexandra Trkola, University of Zurich, Switzerland


 16.05 – 16.20 : Discussion


Session V: The tools to end outbreaks – from science to impact


Chairs: Arnaud Didierlaurent, University of Geneva; Philippe Le Mercier, Swiss Institute of Bioinformatics


16.20 – 16.40
Recoding viral genomes - development of a live-attenuated vaccine platform
Volker Thiel, University of Bern, Switzerland

16.45 – 17.05
Adapting public health to evolving science is critical to combat emerging pathogens: yet a constant source of failures
Gary Kobinger, University of Texas Medical Branch, US

17.10 – 17.30
Putting existing vaccines to use: Insights from a Hepatitis E Vaccine Study in South Sudan and Beyond
Andrew Azman, MSF, Geneva, Switzerland and MSF Switzerland & Johns Hopkins Bloomberg School of Public Health


 17.30 - 17.45 : Discussion


17.45 – 17.55 : Mini-Break


Keynote lectures


Chairs: Arnaud L'Huillier, University Hospitals of Geneva; Ana Rita Conçalves Cabecinhas, University Hospitals of Geneva


17.55 - 18.25

Genomics in a pandemic
Emma Hodcroft, University of Bern and Geneva University Hospitals, Switzerland

18.30 - 19.00
The future of vaccines against respiratory viruses
Florian Krammer, Icahn School of Medicine at Mount Sinai, USA (online)


Social program


19.30 : Conference dinner, Bain des Pâquis, Geneva


 

 Friday December 9, 2022

 Session I: Post Covid – what to expect when the pandemic is over?


Chairs: Manuel Schibler, Geneva University Hospitals; Iris Najjar, Geneva University Hospitals


08.15 - 08.35
Post-COVID: a new reality or what’s next?
Mayssam Nehme, Geneva University Hospitals, Switzerland

08.40 – 09.00
Post Covid, the aftershock of the pandemic
Carmen Scheibenbogen, Charité University Hospital, Berlin (online)


 09.00 – 09.10 : Discussion


Session II: Late breakers in emerging viruses 


Chairs: Nikki Shindo, World Health Organization, Frédérique Jacquerioz-Bausch, University Hospitals of Geneva


09.15 - 09.35
Sudan Ebola virus outbreak in Uganda

Pierre FormentyWorld Health Organization, Geneva, Switzerland


 09.40 – 09.50 : Discussion


09.50 - 10.10: Coffee break


Chairs: Olivia Keiser, University of Geneva; Daniel Bausch, FIND, the global alliance for diagnostics


Out of the box: Emerging viruses , ethics and global responsibility

10.10 – 10.30 : Ethics in a pandemic 

Samia Hurst, University of Geneva

10.35 - 10.55

Access and global responsibility in a pandemic

Maria GuevaraMedecins Sans Frontieres, Geneva, Switzerland


 10.55 – 11.05 : Discussion


Session III: Climate change & a One Health Approach


Chairs: François Chappuis, Geneva University Hospitals; Rafael Ruiz De Castañeda, University of Geneva


11.05 – 11.25
Arboviral diseases & climate Change
Desiree LaBeaud, Stanford University School of Medicine, USA (online)

11.30 – 11.50
Emerging viruses form a veterinary perspective
Barbara Wieland, Institute of Virology and Immunology and University of Bern, Switzerland


 11.55 – 12.05 : Discussion


Award lecture


12.05 – 12.15
Award Ceremony
Laurent Kaiser, Geneva University Hospitals, Switzerland

12.15 – 12.45
Award Lecture
Richard Neher, Biozentrum Basel

12.45 - 12.55
Closing Remarks & Farewell
Laurent Kaiser, Geneva University Hospitals, Switzerland
Isabella Eckerle, Geneva Centre for Emerging Viral Diseases, Switzerland

 

 

 

 

 

logoHUG.png medecine70.gif